医学
糖尿病
2型糖尿病
危险系数
预期寿命
比例危险模型
相对风险
入射(几何)
混淆
疾病
置信区间
累积发病率
内科学
队列
人口
内分泌学
环境卫生
物理
光学
作者
Yin Zhang,Ying Chen,Molin Wang,Ellen Hertzmark,Kana Wu,A. Heather Eliassen,Lorelei A. Mucci,Qi Sun,Meir J. Stampfer,W. C. Willett,Frank B. Hu,Edward L. Giovannucci
摘要
Abstract Background Evidence on type 2 diabetes onset age and duration on mortality risk has been limited by short follow‐up, inadequate control for confounding, missing repeated measurements, and inability to cover the full range of onset age, duration, and major causes of death. Moreover, scarce data dissect how type 2 diabetes onset age and duration shape life expectancy. Methods We evaluate prospectively these topics based on 270,075 eligible participants in the Nurses’ Health Studies and Health Professionals Follow‐up Study, leveraging repeated measurements throughout up to 40 years of follow‐up. Cox models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results In fully adjusted analyses, incident early onset type 2 diabetes (diagnosed <40 years of age) was associated with significantly higher mortality from all‐causes (HR, 95% CI was 3.16, 2.64–3.79; vs. individuals without type 2 diabetes), cardiovascular disease (6.56, 4.27–10.1), respiratory disease (3.43, 1.38–8.51), neurodegenerative disease (5.13, 2.09–12.6), and kidney disease (8.55, 1.98–36.9). The relative risk elevations declined dramatically with each higher decade of age at diagnosis for deaths from most of these causes, though the absolute risk difference increased continuously. A substantially higher cumulative incidence of mortality and a greater loss in life expectancy were associated with younger age at type 2 diabetes diagnosis. Longer disease duration was associated with generally higher relative and absolute risk of mortality. Conclusion Early onset of type 2 diabetes and longer disease duration are associated with substantially increased risk of all‐cause and cause‐specific mortality and greater loss in life expectancy.
科研通智能强力驱动
Strongly Powered by AbleSci AI